RESUMEN
People routinely wear face masks during the pandemic, but little is known about their impact on body perception. In this online study, we presented female body images of Caucasian avatars in common dress sizes displaying happy, angry, and neutral facial expressions with and without face masks, and asked women to rate the perceived body attractiveness and body size. In comparison with mask-off condition, mask-on decreased body attractiveness ratings for happy avatars but did not affect ratings for neutral avatars irrespective of avatar dress sizes. For avatars displaying angry expressions, mask-on increased body attractiveness ratings for slimmer avatars but did not affect ratings for larger avatars. On the other hand, body size estimation was not systematically affected by face masks and facial expressions. It appears that face masks mainly show an expression-dependent influence on body attractiveness judgement, possibly through suppressing the perceived facial expressions.
Asunto(s)
Expresión Facial , Máscaras , Imagen Corporal , Femenino , Felicidad , Humanos , JuicioRESUMEN
Background: Little is known about the relative harms of edible and inhalable cannabis products. Objective: To describe and compare adult emergency department (ED) visits related to edible and inhaled cannabis exposure. Design: Chart review of ED visits between 1 January 2012 and 31 December 2016. Setting: A large urban academic hospital in Colorado. Participants: Adults with ED visits with a cannabis-related International Classification of Diseases, Ninth or 10th Revision, Clinical Modification (ICD-9-CM or ICD-10-CM), code. Measurements: Patient demographic characteristics, route of exposure, dose, symptoms, length of stay, disposition, discharge diagnoses, and attribution of visit to cannabis. Results: There were 9973 visits with an ICD-9-CM or ICD-10-CM code for cannabis use. Of these, 2567 (25.7%) visits were at least partially attributable to cannabis, and 238 of those (9.3%) were related to edible cannabis. Visits attributable to inhaled cannabis were more likely to be for cannabinoid hyperemesis syndrome (18.0% vs. 8.4%), and visits attributable to edible cannabis were more likely to be due to acute psychiatric symptoms (18.0% vs. 10.9%), intoxication (48% vs. 28%), and cardiovascular symptoms (8.0% vs. 3.1%). Edible products accounted for 10.7% of cannabis-attributable visits between 2014 and 2016 but represented only 0.32% of total cannabis sales in Colorado (in kilograms of tetrahydrocannabinol) during that period. Limitation: Retrospective study design, single academic center, self-reported exposure data, and limited availability of dose data. Conclusion: Visits attributable to inhaled cannabis are more frequent than those attributable to edible cannabis, although the latter is associated with more acute psychiatric visits and more ED visits than expected. Primary Funding Source: Colorado Department of Public Health and Environment.
Asunto(s)
Cannabis/efectos adversos , Fumar Marihuana/efectos adversos , Plantas Comestibles/efectos adversos , Enfermedad Aguda , Adulto , Cannabis/envenenamiento , Enfermedades Cardiovasculares/inducido químicamente , Colorado , Servicio de Urgencia en Hospital , Femenino , Humanos , Masculino , Persona de Mediana Edad , Psicosis Inducidas por Sustancias/etiología , Estudios Retrospectivos , Vómitos/inducido químicamenteAsunto(s)
Administración por Inhalación , Abuso de Marihuana/complicaciones , Enfermedades Cardiovasculares/etiología , Colorado/epidemiología , Servicio de Urgencia en Hospital/organización & administración , Humanos , Abuso de Marihuana/epidemiología , Abuso de Marihuana/fisiopatología , Trastornos Mentales/etiología , Estudios Retrospectivos , Vómitos/etiologíaRESUMEN
Background: Cannabis (MJ) policy liberalization in a majority of US states has impacted emergency department (ED) visits. It is important to understand why people come to the ED after using MJ because the drug is now available to experienced and naïve people across the country. The objectives of this study were to (1) improve upon administrative dataset methodology by performing additional chart review to describe ED visits related to cannabis, (2) understand why patients come to the ED after using cannabis, and (3) begin to inform our understanding of cannabis-attributable ED visits to start to educate patients and providers about cannabis' safety.Methods: We performed a retrospective chart review of ED visits identified by cannabis ICD-9 and 10-CM codes between 2012 and 2016. Visits were reviewed and determined if the visit was partially attributable to cannabis based upon a pre-specified definition, then categorized into clinical complaint categories. Descriptive statistics, Chi-Square, and T-tests were used to elucidate the data.Results: About one-fourth (25.74%) of visits with cannabis ICD-CM codes were found to be at least partially attributable to cannabis. These patients are more often young, Caucasian males when compared to the overall ED population (p < .0001). Patients with a cannabis-attributable visit were more often admitted to the hospital (p < .0001). The most common complaints in cannabis-attributable visits were gastrointestinal and psychiatric complaints, as well as intoxication. The number of cannabis-attributable visits rose with time (p=.012).Conclusions: Based on a pre-specified definition, with good inter-rater reliability, we found that 25% of visits with a cannabis ICD-CM code were partially attributable to cannabis. These findings represent areas to target in cannabis user education as public perceptions change across time.
Asunto(s)
Cannabis/efectos adversos , Servicio de Urgencia en Hospital/estadística & datos numéricos , Abuso de Marihuana/epidemiología , Estudios de Cohortes , Colorado , Femenino , Humanos , Masculino , Registros Médicos/estadística & datos numéricos , Educación del Paciente como Asunto , Estudios Retrospectivos , Encuestas y Cuestionarios , Adulto JovenRESUMEN
The Emergency Medicine Specimen Bank (EMSB) was developed to facilitate precision medicine in acute care. The EMSB is a biorepository of clinical health data and biospecimens collected from all adult English- or Spanish-speaking individuals who are able and willing to provide consent and are treated at the UCHealth-University of Colorado Hospital Emergency Department. The EMSB is the first acute care biobank that seeks to enroll all patients, with all conditions who present to the ED. Acute care biobanking presents many challenges that are unique to acute care settings such as providing informed consent in a uniquely stressful and fast-paced environment and collecting, processing, and storing samples for tens of thousands of patients per year. Here, we describe the process by which the EMSB overcame these challenges and was integrated into clinical workflow allowing for operation 24 hours a day, 7 days a week at a reasonable cost. Other institutions can implement this template, further increasing the power of biobanking research to inform treatment strategies and interventions for common and uncommon phenotypes in acute care settings.